Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,323 recruiting studies in this area right now.
By phase
- Not applicable4,385
- Phase 2610
- Phase 1414
- Phase 3321
- Phase 4268
- Phase 1/Phase 2255
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer340
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer191
- Acute Kidney Injury136
- Endometriosis135
- Chronic Kidney Diseases131
- Pregnancy131
- Breast Cancer106
- Chronic Kidney Disease104
- Infertility95
- Renal Cell Carcinoma80
- Colorectal Cancer76
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Urinary Incontinence64
- Lung Cancer62
Leading sponsors
- Mayo Clinic58
- Assistance Publique - Hôpitaux de Paris47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca35
Where studies are running
- California345
- Alabama156
- Texas121
- Massachusetts119
- New York118
- Florida102
- Arizona101
- Colorado90
- Maryland90
- Illinois79
Recruiting studies6,323 total
- NCT07166822Recruiting
Can a mobile app help you stay active during pregnancy?
This study tests if using a mobile app can help pregnant women who are not very active to exercise more safely and improve their heart health. It's for women with low-risk pregnancies who want to use a simple smartphone tool.
Norfolk, VirginiaAges 18–45 - NCT07109258RecruitingEarly Phase 1
Dexamethasone for labor induction at full term
This trial tests if giving dexamethasone helps start labor in first-time mothers who are at full term (39 weeks or more) and have no complications. It aims to make the induction process more effective.
Cairo, ManialAges 18 years+ - NCT07109076Recruiting
Immediate skin contact after C-section and baby's heart rate
This study looks at how holding your baby skin-to-skin right after a planned C-section affects their heart rate patterns. It may help understand benefits for you and your newborn.
Ljubljana, LjubljanaAges birth+ - NCT05760144RecruitingEarly Phase 1
Endometrial biopsy study in people using hormonal birth control
This early-phase study looks at doing an endometrial biopsy (a small tissue sample from the uterus) in people using a progestin-type contraceptive. It’s meant to test whether this approach works safely and how the uterus responds under these specific conditions.
Portland, OregonAges 18–40 - NCT07110285Recruiting
AI vs. doctor decision for IVF trigger day
This trial compares an artificial intelligence (AI) algorithm to doctors to decide the best day to give the trigger shot during IVF. It aims to see if AI can improve the number of mature eggs retrieved.
HerzliyaAges 18–45 - NCT06493357Recruiting
Improving HIV testing and care for mothers and babies in Malawi
This study is testing a new way to find and treat HIV in pregnant women and new mothers in Malawi. It may help prevent passing HIV from mother to baby.
Lilongwe, Central RegionAges 16 years+ - NCT05726305Recruiting
Uterus transplant for women who cannot carry a pregnancy
This trial studies transplanting a uterus to allow people with uterine infertility to try pregnancy. It may help some patients who cannot carry a baby because their uterus is missing or nonfunctional, but it requires careful matching and strict health screening for both recipients and donors.
RennesAges 18 years+ - NCT07555093Recruiting
Micronutrient Supplements and Digital Health Tracking in Pregnancy
This study tests whether taking micronutrient supplements (vitamins and minerals) along with a digital app or text reminders helps pregnant women stay on track with their prenatal care. The goal is to improve nutrition and health outcomes during pregnancy.
Mataram, West Nusa TenggaraAges 14 years+ - NCT06515301Recruiting
Improving follow-up after cervical precancer treatment
This study in Ethiopia looks at ways to help women stay on track with follow-up visits after treatment for cervical precancer. It tests simple support methods to improve adherence.
Silte, Southern EthiopiaAges 25–49 - NCT07036536Recruiting
Non-Euploid Embryo Transfer Registry
This registry is collecting information from people who plan to transfer an embryo that is not genetically normal (non-euploid) at a fertility clinic in The Prelude Network. It will help doctors learn more about outcomes with these embryos.
Houston, TexasAges Any age - NCT05974618Recruiting
Testing an ultrasound model to sort pregnancy ovarian cysts
This study checks how well a specific ultrasound-based scoring tool can tell the difference between harmless (non-cancer) and harmful (cancer) ovarian masses during pregnancy. If you have a cyst or mass that’s at least 5 cm, your scan details may be used to validate the tool.
Leuven, Vlaams-BrabantAges 18–50 - NCT07311577RecruitingPhase 2
Trial of a drug combo for HER2-positive ovarian cancer
This trial tests a combination of disitamab vedotin, platinum chemotherapy, and bevacizumab as first treatment for high-risk ovarian cancer that has a protein called HER2. The goal is to see if this therapy helps control the cancer and keeps it from growing.
Nanjing, JiangsuAges 18–75 - NCT07083999Recruiting
Fertility support for women 32 to 38 trying to conceive
This study looks at how the Ovosicare® Fertility supplement affects fertility in women between 32 and 38 years old who have been trying to get pregnant for at least six months. It's a way to see if this product can help improve your chances of conceiving.
Sitges, BarcelonaAges 32–38 - NCT06335017Recruiting
Castor oil and balloon for inducing labor in second-time moms
This study tests whether drinking castor oil combined with a balloon catheter can safely start labor in women who have given birth before. It may help avoid more medical interventions during labor induction.
NazarethAges 18–60 - NCT06332742Recruiting
Herbal formula for low egg reserve in women ages 25–45
This trial tests a Chinese herbal formula called Qingxin Zishen Decoction to see if it can improve egg health and hormone levels in women with low ovarian reserve. It may be an option if you are between 25 and 45 and have not had surgery or hormone treatments recently.
Nanjing, JiangsuAges 25–45 - NCT06216002Recruiting
Residual paralysis after cancer surgery in frail patients
This trial checks how often muscle relaxant effects linger after gynecologic cancer surgery, especially in frail patients. It uses a nerve stimulator to measure muscle function after surgery.
Bangkok, BangkokAges 18 years+ - NCT06279104Recruiting
Comparing treatments for ovarian clear cell carcinoma
This study compares different ways to treat ovarian clear cell carcinoma, a rare type of ovarian cancer. It is for women whose cancer has come back or not gone away after platinum chemotherapy, or those newly diagnosed.
Wuhan, HubeiAges 18–75 - NCT06134609Recruiting
Does sex affect frozen embryo transfer success?
This study looks at whether having sex (vaginal intercourse) around the time of a frozen embryo transfer affects the chance of pregnancy. If you are a woman under 42 with a good quality embryo and can have vaginal intercourse, you may be able to join.
Ramat GanAges 18–41 - NCT06005311Recruiting
Comparing sperm preparation methods in IVF
This trial compares two ways of preparing sperm for IVF: a new microfluidic chip method versus the standard density-gradient centrifugation. It aims to see which method leads to more successful fertilizations and pregnancies.
Hong Kong, Hong KongAges Up to 43 years - NCT07104149RecruitingPhase 2
Chemo plus immunotherapy before surgery for cervical cancer
This trial tests adding a new immunotherapy drug (cadonilimab) to standard chemotherapy before surgery for locally advanced cervical cancer. The goal is to see if this combination helps shrink the tumor more effectively before surgery.
Zhengzhou, HenanAges 18–75 - NCT07131215Recruiting
Smart technology for health in early menopause
This trial tests whether a smartphone-based program can help monitor and improve the physical and mental health of women who have recently gone through menopause. It aims to see if technology can support healthy lifestyle changes during this transition.
TainanAges 40–65 - NCT06042803Recruiting
Study on medicine levels in breastmilk
This study looks at how medicines pass into breastmilk. It helps understand the safety of medications while breastfeeding. If you take medicine and breastfeed, this study may be an option for you.
Leuven, Vlaams-BrabantAges 18 years+ - NCT05341817RecruitingPhase 4
Letrozole or mifepristone before medication abortion
This study tests whether taking letrozole or mifepristone before medication helps the medical abortion work better for pregnancies up to 10 weeks. You may be asked to try another method (repeat medicine or a procedure) if the first treatment does not fully work.
SingaporeAges 21 years+ - NCT06089109Recruiting
Helping students prevent violence-related maternal deaths
This trial trains students in helping professions to support people at risk of violence during pregnancy. The goal is to reduce pregnancy-related deaths.
Lexington, KentuckyAges 18–30
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,323 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,225 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.